#CART16 Conference Hashtag

Clinical Application of CAR T Cells

Chimeric antigen receptor (CAR) T-cell (’Living Drug’) immunotherapy is showing promising results in the treatment of cancers. In addition to the MSK faculty, national and international experts will discuss clinical and translational aspects of CARs, both for hematological malignancies and solid tumors. https://www.mskcc.org/event/car-t-cell

#CART16 is a conference hashtag submitted by @DrMiguelPerales